Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Solventum Corporation Common Stock (NY:SOLV)

88.51 -1.03 (-1.15%)
Streaming Delayed Price Updated: 11:57 AM EDT, Sep 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Solventum Corporation Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
2 Profitable Stocks for Long-Term Investors and 1 We Question
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does... 
Via StockStory
Solventum (NYSE:SOLV) Forms Tight Breakout Setup as Technical Strength Builds ↗
Via Chartmill
News headline image
Due Diligence Check: Do These "Blue Chips" Still Earn the Title? ↗
"Blue chip" gets applied to a company once and tends to stick, regardless of what the balance sheet does afterward. The label describes reputation, not cur 
Via Talk Markets
News headline image
Q2 Surgical Equipment & Consumables - Diversified Earnings: Solventum (NYSE:SOLV) Impresses
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking a... 
Via StockStory
Topics Artificial Intelligence Economy
News headline image
3 S&P 500 Stocks with Open Questions
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant ch... 
Via StockStory
Topics Stocks
News headline image
2 Mid-Cap Stocks to Consider Right Now and 1 That Underwhelm
Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the man... 
Via StockStory
Topics Energy
News headline image
3 Value Stocks with Open Questions
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The ... 
Via StockStory
News headline image
3 Reasons to Avoid SOLV and 1 Stock to Buy Instead
Solventum’s 22% return over the past six months has outpaced the S&P 500 by 10.4%, and its stock price has climbed to $89.05 per share. This was partly due t... 
Via StockStory
Topics Stocks
News headline image
1 Healthcare Stock for Long-Term Investors and 2 Facing Challenges
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry... 
Via StockStory
News headline image
Solventum (SOLV) Q2 2026 Earnings Call Transcript ↗
CEO Hanson discusses HIS separation strategy and $2.2B in quarterly sales growth. 
Via The Motley Fool
Topics Earnings World Trade
News headline image
Q2 Rundown: STERIS (NYSE:STE) Vs Other Surgical Equipment & Consumables - Diversified Stocks
The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how surgical equipment & c... 
Via StockStory
Topics Artificial Intelligence Economy
News headline image
Solventum Q2 Earnings Call Highlights ↗
Solventum (NYSE:SOLV) reported second-quarter results that exceeded its internal expectations, supported by broad-based segment performance, planned order activity ahead of an ERP cutover and a tariff... 
Via MarketBeat
Topics ETFs Earnings World Trade
News headline image
SOLV Q2 Deep Dive: Portfolio Restructuring and ERP Transition Shape Outlook
Healthcare solutions provider Solventum (NYSE:SOLV) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 2.2% year on year to $2.... 
Via StockStory
News headline image
Solventum Nears Inflection Point As It Begins to Unlock Value ↗
Solventum shares gain on strong Q2 revenue, earnings, and cash flow, buybacks, and improved guidance, with analysts raising price targets amid a discounted valuation versus med/tech peers. 
Via MarketBeat
Topics Initial Public Offering
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Via Chartmill
News headline image
Solventum (NYSE:SOLV) Posts Better-Than-Expected Sales In Q2 CY2026
Healthcare solutions provider Solventum (NYSE:SOLV) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 2.2% year on year to ... 
Via StockStory
Stay updated with the S&P500 stocks that are on the move in today's after-hours session. ↗
Via Chartmill
News headline image
What To Expect From Solventum’s (SOLV) Q2 Earnings
Healthcare solutions provider Solventum (NYSE:SOLV) will be reporting results this Wednesday after market hours. Here’s what you need to know. Solventum beat... 
Via StockStory
News headline image
3 Hyped Up Stocks That Fall Short
Each stock in this article is trading near its 52-week high. These elevated prices usually indicate some degree of investor confidence, business improvements... 
Via StockStory
Exploring the top movers within the S&P500 index during today's session. ↗
Via Chartmill
Tuesday's session: top gainers and losers in the S&P500 index ↗
Via Chartmill
These S&P500 stocks are gapping in today's session ↗
Via Chartmill
News headline image
3 Reasons SOLV is Risky and 1 Stock to Buy Instead
Since January 2026, Solventum has been in a holding pattern, posting a small loss of 2.2% while floating around $77.29. The stock also fell short of the S&P ... 
Via StockStory
Topics Stocks
News headline image
2 S&P 500 Stocks to Own for Decades and 1 We Question
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant ch... 
Via StockStory
Topics Stocks
News headline image
3 Mid-Cap Stocks We Steer Clear Of
Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to beco... 
Via StockStory
News headline image
3 Healthcare Stocks with Questionable Fundamentals
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have realiz... 
Via StockStory
What's going on in today's pre-market session: S&P500 movers ↗
Via Chartmill
What's going on in today's session: S&P500 movers ↗
Via Chartmill
News headline image
1 Profitable Stock with Exciting Potential and 2 That Underwhelm
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does... 
Via StockStory
Top S&P500 movers in Monday's session ↗
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.